ProBiotix Health expands heart health range with CholBiome®VH

The formulation is designed to help combat atherosclerosis in adults using clinically studied, patented ingredients. ProBiotix has developed a new finished formulation to advance heart health formulas for high end supplement and online brands in the nutraceutical market. To support the reduction in vascular calcification and plaque formation (atherosclerosis) in arteries, ProBiotix has launched CholBiome®VH (Vascular […]

Conscious eating and its impact on lowering blood pressure

Food trends constantly wax and wane, but there is one movement in the food industry that is here to stay: ‘conscious eating.’ This trend was recently confirmed by marketing insights firm McKinsey in an online survey targeting 8,000 consumers in the US, UK, France and Germany.1 During the survey, at least 70% of respondents indicated […]

ProBiotix Health launches new dual-action cholesterol reducing bi-layer tablet CholBiome®CH at Vitafoods Europe

ProBiotix Health plc (‘ProBiotix’), a global market leader in microbiome modulation technology in the life sciences industry, has added to its growing range of science-backed cholesterol-reducing products with CholBiome®CH. The latest innovation from ProBiotix, which will launch at Vitafoods Europe this year, is a result of new regulations from the European Food Safety Authority (EFSA) […]

Reducing bad cholesterol with LPLDL

Heart and circulatory diseases cause approximately one in three deaths globally, which is around 19 million deaths per year. According to research from the British Heart Foundation, if the global population does not take action to reduce its cardiovascular disease (CVD) risk, the number of deaths could rise to more than 23 million by 2030 […]